药物基因组学多基因风险评分:准备好还是不准备好?
Sonal Singh1, Gabriele Stocco2,3, Katherine N Theken4
1Merck & Co., Inc, South San Francisco, California, USA.
药物遗传学多基因风险评分 (PRS) 可以预测药物反应,但面临挑战. 建议包括标准化方法,协作和更好的临床使用基础设施.
科学领域:
- 药物基因组学和精准医学
背景情况:
- 药物遗传学多基因风险评分 (PRS) 是基于多个遗传变异预测药物反应的工具.
- 目前的PRS通常依赖于疾病遗传学,限制其直接适用于药物遗传学.
研究的目的:
- 审查目前的药物遗传学PRS的现状.
- 确定阻碍其临床实施的机遇和挑战.
- 为推进药物遗传学PRS提出建议.
主要方法:
- 对药物遗传学PRS的最新证据的审查.
- 评估药物基因组学研究和PRS开发中的现有挑战.
- 为未来的研究和临床整合制定建议.
主要成果:
- 挑战包括依赖疾病遗传学,小样本大小和不一致的表型.
- 机遇在于开发药物特定的PRS,并将基因组数据与临床预测因素整合起来.
结论:
- 标准化表型,加强合作和开发新的统计方法至关重要.
- 改进的基础设施,用户友好的工具,患者教育和解决伦理问题是临床采用所必需的.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
相关概念视频
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Analysis of Population Pharmacokinetic Data
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
